Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas (Q39608984)

From Wikidata

Jump to navigation Jump to search

scientific article published on 12 January 2011

Language	Label	Description	Also known as
English	Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas	scientific article published on 12 January 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Lars Steinstraesser

7

object named as

Lars Steinstraesser

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

6

object named as

Jennifer Hauk

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

Markus Vogt

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Johanna Munding

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Martha Grüner

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sven-Thorsten Liffers

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Berlinda Verdoodt

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Andrea Tannapfel

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Heiko Hermeking

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

12 January 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

458

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

313-322

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

MicroRNAs in Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

p53 enters the microRNA world

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Causes and consequences of microRNA dysregulation in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Transcriptional activation of miR-34a contributes to p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

A microRNA component of the p53 tumour suppressor network

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

The miR-34 family in cancer and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

The epigenomics of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

The power and the promise of DNA methylation markers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

An oncogene-induced DNA damage model for cancer development

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

A microRNA DNA methylation signature for human cancer metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Frequent downregulation of miR-34 family in human ovarian cancers

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

MicroRNAs impair MET-mediated invasive growth

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Evidence linking CD44-positive cells and gemcitabine resistance in pancreatic cancer cells: need for further substantiation

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

TP53 mutation in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Epigenetic inactivation of the miR-34a in hematological malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1030-5

21 January 2018

Is there a role for routine p53 testing in colorectal cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Worms gang up on bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-34c is downregulated in prostate cancer and exerts tumor suppressive functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The fundamental role of epigenetic events in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21225432

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-010-1030-5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39608984&oldid=2203020832"